Find an expert
Our panel of editors are available for interview
Theodora Bloom
Executive Editor of the BMJ
Theodora Bloom is executive editor of The BMJ. At the BMJ, Theo’s responsibilities include publishing, business, platform and operations as well as ethical and policy matters. She is a Co-Founder of the medRxiv preprint server, a collaboration between BMJ, Cold Spring Harbor Laboratory and Yale University, and jointly coordinates open access and open research initiatives at BMJ.
Professor Juan Víctor Ariel Franco
Editor-in-Chief of BMJ Evidence-Based Medicine
Professor Juan Franco is a family doctor at the Hospital Italiano de Buenos Aires, Argentina, and Vice-chair of the Research Department at the Instituto Universitario Hispital Italiano (IUHI), where he is also Director of the Cochrane Associate Centre. He is a professor at IUHI and Universidad Nacional de La Matanza, and editor for the Cochrane Urology Group and a member of Cochrane’s Governing Board.
Professor Hans Kromhout
Editor-in-Chief of Occupational & Environmental Medicine
Professor Hans Kromhout is an occupational hygiene and epidemiology specialist, based at the Institute for Risk Assessment Sciences at Utrecht University in the Netherlands. Professor Kromhout’s work has covered the health effects of chemical and physical (EMF) agents in the workplace and general environment. He has been the (co-)PI of large international studies in among others the asphalt industry, rubber manufacturing industry, industrial minerals industry, health sector and agriculture and community based studies on cancer, respiratory diseases, neurodegenerative diseases and reproductive health effects.
Professor Ganesan Karthikeyan
Editor-in-Chief Open Heart
Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.
